Supply and manufacturing line final
Work going on at Oxford University
Medicine will reach the whole world
Many others are also involved in making vaccine
Medicine from seven centers to the whole world
New Delhi: Preparations are on full swing to put themselves ahead in the Battle
of Corona in Britain. In this sequence, she has started work on the plan to prepare
one million vaccines before the clinical trial is completed. Actually this
preparation is so that.
There is no delay in starting the production of Vaccine if it is to meet the
standards of World Health Organization. With the production line already in
operation, this work can be started from the very next moment of recognition.
Meanwhile, Corona appears to be getting a bit less in the UK. But even after this,
he does not want to leave any effort in the investigation of infection. Every citizen
of the transition area is being investigated and the investigation is being analyzed
at a rapid pace. The actual status of India is not known because the process of
investigation is very slow here and very few people have been examined here in
proportion to the population.
This preparation in Britain is preparing to bring medicine by September
British scientists have already started making the vaccine so that it can be
available in sufficient quantity by September. Meanwhile, preliminary reports of
vaccine trials are also expected. The team at the University of Oxford in the UK
designed a test product.
This is named CHADOX1 NCOV-19. It is actually a mixture of many medicines.
It’s classified as a viral vectors vaccine. 70 other vaccines of the same variety are
also involved in the trial and research race. Five of these 70 are also being tested
being reinstated for preliminary stage investigations. The work has been done to
secure stock by completing all the preparations for production so that whichever
vaccine is recognized, its use can start immediately and at the same time its
production can be speed up. Excess production is not being done because the
vaccine will go waste if proved unsuccessful and the expenditure in their
production will be wasted.
Adrienne Hill, director and professor at the Jennifer Institute of Oxford
University, associated with this task, said that we have made arrangements for its
early production all over the world despite low production. They can be produced
simultaneously at seven locations all over the world. This has been done so that
this vaccine can be made available to every part of the world as soon as possible
after production starts. That will take additional resources and time to keep it focused
around the world. In the current phase of challenge, it is the priority to reach
people soon. According to him, there is a subsidiary company for this work in
India too, which will start this work as soon as it gets the green signal. All the
preparations for its production in India have also been completed.
Lot of money invested in this project
Regarding this research, scientists believe that this is a huge economic risk
because millions of pounds have been spent on these preparations. Even after not
giving details of this expenditure, scientists believe that a lot of arrangements
have to be made in the preparations for fast production. Economic expenses are
definitely included in all those preparations. So far, more than 2 million people
have been affected by this corona virus worldwide and this figure is increasing
every day. The initial trial of vaccine is also to be done only among people of
certain age groups, it has been announced by the scientific team. Only people
between the ages of 18 and 55 will be included in this vaccine trial. After getting
the right result, it will be tried slowly on people of other ages as well. Five
thousand volunteers will participate in the final phase of the trial.
British government also in favor of these preparations
On the other hand, the British Government has said that the plan to bring the
vaccine to the public soon has its full support. Therefore, the government has also
invested £ 14 million in capital for all these schemes. Work is underway on 21
projects. The purpose of all this is to make vaccine for Corona soon. In this work,
two such institutions are also connected which are not connected with the
business of making profit. This information was given by UK Finance Minister
Alok Sharma. According to Mr. Sharma, a separate task force has also been
constituted for this, which is authorized to take quick decision in this regard by
mutual coordination. The task force is headed by Chief Scientific Officer Patrick
Valence, while the team includes Professor Jonathan van Tam.